Altered brain functional networks in schizophrenia with persistent negative symptoms: an activation likelihood estimation meta-analysis.
central executive network
default mode network
functional connectivity
gray matter volume
persistent negative symptoms
salience network
Journal
Frontiers in human neuroscience
ISSN: 1662-5161
Titre abrégé: Front Hum Neurosci
Pays: Switzerland
ID NLM: 101477954
Informations de publication
Date de publication:
2023
2023
Historique:
received:
12
04
2023
accepted:
10
10
2023
medline:
13
11
2023
pubmed:
13
11
2023
entrez:
13
11
2023
Statut:
epublish
Résumé
To investigate brain structural and functional characteristics of three brain functional networks including default mode network (DMN), central executive network (CEN), and salience network (SN) in persistent negative symptoms (PNS) patients. We performed an activation likelihood estimation (ALE) meta-analysis of functional connectivity (FC) studies and voxel-based morphometry (VBM) studies to detect specific structural and functional alterations of brain networks between PNS patients and healthy controls. Seventeen VBM studies and twenty FC studies were included. In the DMN, PNS patients showed decreased gray matter in the bilateral medial frontal gyrus and left anterior cingulate gyrus and a significant reduction of FC in the right precuneus. Also, PNS patients had a decrease of gray matter in the left inferior parietal lobules and medial frontal gyrus, and a significant reduction of FC in the bilateral superior frontal gyrus in the CEN. In comparison with healthy controls, PNS patients exhibited reduced gray matter in the bilateral insula, anterior cingulate gyrus, left precentral gyrus and right claustrum and lower FC in these brain areas in the SN, including the left insula, claustrum, inferior frontal gyrus and extra-nuclear. This meta-analysis reveals brain structural and functional imaging alterations in the three networks and the interaction among these networks in PNS patients, which provides neuroscientific evidence for more personalized treatment.Systematic Review RegistrationThe PROSPERO (https://www.crd.york.ac.uk/PROSPERO/, registration number: CRD42022335962).
Identifiants
pubmed: 37954938
doi: 10.3389/fnhum.2023.1204632
pmc: PMC10637389
doi:
Types de publication
Systematic Review
Langues
eng
Pagination
1204632Informations de copyright
Copyright © 2023 Zhu, Wang, Wu, Ling, Wang, Zhou, Fang, Huang, Xie, Chen and Zhang.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Transl Psychiatry. 2015 Jun 02;5:e575
pubmed: 26035059
Neurosci Lett. 2016 Aug 3;627:178-84
pubmed: 27233217
Psychiatry Res. 2015 Feb 28;231(2):103-10
pubmed: 25498920
Front Hum Neurosci. 2016 Mar 30;10:132
pubmed: 27064387
JAMA Psychiatry. 2013 Apr;70(4):361-72
pubmed: 23389420
Am J Psychiatry. 1988 May;145(5):578-83
pubmed: 3358462
Front Psychiatry. 2017 Jul 20;8:127
pubmed: 28775696
Prog Neuropsychopharmacol Biol Psychiatry. 2005 May;29(4):587-91
pubmed: 15866362
Schizophr Bull. 2016 Jul;42 Suppl 1:S13-21
pubmed: 27460615
Acta Psychiatr Scand. 2011 Jun;123(6):431-9
pubmed: 21054282
Neural Plast. 2020 Dec 10;2020:8859388
pubmed: 33381163
Schizophr Res. 2018 Dec;202:195-202
pubmed: 30049600
Psychiatry Res Neuroimaging. 2018 Jan 30;271:17-23
pubmed: 29220695
Br J Psychiatry. 2017 Jan;210(1):75-82
pubmed: 26892851
Psychol Med. 2022 Sep;52(12):2270-2280
pubmed: 33183375
Sci Rep. 2015 Sep 25;5:14505
pubmed: 26403064
Schizophr Bull. 2014 Mar;40(2):428-37
pubmed: 23519021
Psychiatry Res Neuroimaging. 2019 Oct 30;292:32-40
pubmed: 31499256
J Affect Disord. 2012 Dec 20;143(1-3):56-63
pubmed: 22749158
Schizophr Bull. 2010 Sep;36(5):919-34
pubmed: 20566491
Neuroimage. 2000 Jun;11(6 Pt 1):805-21
pubmed: 10860804
Neuroinformatics. 2016 Jul;14(3):339-51
pubmed: 27075850
Schizophr Res. 2008 Sep;104(1-3):44-60
pubmed: 18703313
Cereb Cortex. 2009 Jan;19(1):72-8
pubmed: 18403396
Cereb Cortex. 2019 Jul 22;29(8):3577-3589
pubmed: 30272139
Psychiatry Res. 1994 Oct;54(1):59-69
pubmed: 7701029
Neuroimage. 2020 Apr 15;210:116543
pubmed: 31940475
Trends Cogn Sci. 2011 Oct;15(10):483-506
pubmed: 21908230
Brain Imaging Behav. 2020 Jun;14(3):869-880
pubmed: 30612342
Front Hum Neurosci. 2013 May 20;7:216
pubmed: 23730284
Int J Neural Syst. 2019 Jun;29(5):1850032
pubmed: 30149746
Front Psychiatry. 2019 Apr 26;10:275
pubmed: 31105606
Br J Psychiatry Suppl. 1989 Nov;(7):49-58
pubmed: 2695141
Front Behav Neurosci. 2014 Nov 19;8:404
pubmed: 25477799
Brain Res Bull. 2003 Oct 15;61(6):557-69
pubmed: 14519452
Psychiatry Res Neuroimaging. 2016 Oct 30;256:26-32
pubmed: 27662482
Schizophr Bull. 2007 Jul;33(4):1004-12
pubmed: 17556752
Eur Neuropsychopharmacol. 2013 Mar;23(3):196-204
pubmed: 22647933
Lancet Psychiatry. 2018 Aug;5(8):664-677
pubmed: 29602739
Am J Psychiatry. 2001 Feb;158(2):234-43
pubmed: 11156806
Sci Rep. 2016 May 18;6:26124
pubmed: 27188233
Cogn Affect Behav Neurosci. 2016 Dec;16(6):991-1002
pubmed: 27444935
PLoS One. 2015 Mar 06;10(3):e0119176
pubmed: 25748858
Acta Psychiatr Scand. 2009 Mar;119(3):199-208
pubmed: 19016669
Neuropsychopharmacology. 2021 Jul;46(8):1502-1509
pubmed: 33408329
Schizophr Res. 2001 May 30;50(1-2):19-26
pubmed: 11378311
Schizophr Bull. 2012 Jun;38(4):796-802
pubmed: 21205677
Eur Neuropsychopharmacol. 2014 May;24(5):744-58
pubmed: 24183826
Brain Stimul. 2020 May - Jun;13(3):840-849
pubmed: 32289715
Psychiatry Res. 2009 Mar 31;171(3):155-65
pubmed: 19217758
Schizophr Bull. 2013 Sep;39(5):1129-38
pubmed: 23042112
Schizophr Bull. 2006 Apr;32(2):214-9
pubmed: 16481659
Psychiatry Res. 2009 Jun 30;172(3):175-9
pubmed: 19395244
Biol Psychiatry. 2011 May 15;69(10):967-73
pubmed: 21193174
Schizophr Bull. 2011 Mar;37(2):300-5
pubmed: 20558531
Nat Neurosci. 2002 Mar;5(3):267-71
pubmed: 11865311
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Schizophr Bull. 2007 Jul;33(4):1013-22
pubmed: 17099070
Prog Neurobiol. 2004 Sep;74(1):1-58
pubmed: 15381316
Trends Cogn Sci. 2011 Feb;15(2):85-93
pubmed: 21167765
Sci Rep. 2015 Jun 09;5:11258
pubmed: 26058049
BMC Psychiatry. 2017 Jan 31;17(1):45
pubmed: 28143464
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):676-82
pubmed: 11209064
Front Psychiatry. 2015 Feb 26;6:26
pubmed: 25767449
Schizophr Res. 2007 Jul;93(1-3):1-12
pubmed: 17399954
J Neurophysiol. 2011 Nov;106(5):2322-45
pubmed: 21795627
Am J Psychiatry. 2013 Feb;170(2):165-72
pubmed: 23377637
Neuroimage. 2008 Feb 15;39(4):1600-12
pubmed: 18054834
Schizophr Bull. 2009 Sep;35(5):973-93
pubmed: 18436528
Trends Cogn Sci. 2004 Sep;8(9):396-403
pubmed: 15350240
J Affect Disord. 2016 Jan 1;189:290-7
pubmed: 26454335
Schizophr Res. 2011 Jul;129(2-3):163-8
pubmed: 21497489
Clin EEG Neurosci. 2018 Jan;49(1):27-35
pubmed: 29243526
Am J Psychiatry. 2019 Jul 1;176(7):512-520
pubmed: 30696271
Schizophr Res. 2021 Jul;233:89-96
pubmed: 34246865
Am J Med Genet B Neuropsychiatr Genet. 2020 Mar;183(2):106-112
pubmed: 31626393
Eur Arch Psychiatry Clin Neurosci. 2007 Feb;257(1):58-62
pubmed: 16960651
Trends Cogn Sci. 2000 Jun;4(6):215-222
pubmed: 10827444
Neurosci Bull. 2013 Feb;29(1):59-74
pubmed: 23319314
Neuroimage. 2004 Mar;21(3):840-7
pubmed: 15006650
Front Neurol. 2020 Apr 28;11:272
pubmed: 32411071
World J Biol Psychiatry. 2004 Jan;5(1):20-5
pubmed: 15048631
Brain Res. 2014 May 8;1562:87-99
pubmed: 24675026
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
Schizophr Res. 2013 Aug;148(1-3):74-80
pubmed: 23727217
Psychiatry Res Neuroimaging. 2019 Jun 30;288:12-20
pubmed: 31059954
Brain Imaging Behav. 2018 Oct;12(5):1457-1465
pubmed: 29297153
Schizophr Bull. 2018 Jan 13;44(1):168-181
pubmed: 28338943
Schizophr Bull. 2014 Sep;40(5):1095-104
pubmed: 24243441
Biol Psychiatry. 2008 Mar 1;63(5):465-74
pubmed: 17689500
J Psychiatry Neurosci. 2011 Nov;36(6):366-74
pubmed: 21791169
Hum Brain Mapp. 2017 Jan;38(1):7-11
pubmed: 27511454
J Psychiatr Res. 2022 Jan;145:263-275
pubmed: 33187692
Front Syst Neurosci. 2016 Dec 27;10:104
pubmed: 28082874
PLoS One. 2017 May 17;12(5):e0177251
pubmed: 28520743
Brain Imaging Behav. 2020 Oct;14(5):1350-1360
pubmed: 30689171
Int J Neuropsychopharmacol. 2015 Feb 25;18(7):pyv016
pubmed: 25716781
Schizophr Res. 2015 Feb;161(2-3):261-8
pubmed: 25468173
Schizophr Res. 2018 Feb;192:9-15
pubmed: 28390850
Ann N Y Acad Sci. 2008 Mar;1124:1-38
pubmed: 18400922
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:412-420
pubmed: 30822447
Front Syst Neurosci. 2010 Apr 06;4:8
pubmed: 20407579
Early Interv Psychiatry. 2017 Feb;11(1):77-82
pubmed: 26256570
Sci Rep. 2020 Feb 13;10(1):2616
pubmed: 32054907
BMC Psychiatry. 2017 Mar 21;17(1):105
pubmed: 28327107
PLoS One. 2014 Jun 30;9(6):e101372
pubmed: 24979583
Psychiatry Res Neuroimaging. 2018 Feb 28;272:7-16
pubmed: 29247717
Schizophr Res. 2010 Jul;120(1-3):63-70
pubmed: 20452187
Eur Neuropsychopharmacol. 2014 May;24(5):725-36
pubmed: 24461724
J Neurophysiol. 2011 Sep;106(3):1125-65
pubmed: 21653723
Int J Environ Res Public Health. 2020 Aug 27;17(17):
pubmed: 32867189
Chronic Stress (Thousand Oaks). 2018 Dec 10;2:2470547018815232
pubmed: 32440588
Schizophr Bull. 2011 Jan;37(1):177-88
pubmed: 19633214
Cereb Cortex. 2009 Oct;19(10):2209-29
pubmed: 19221144
Neurosci Biobehav Rev. 2011 Apr;35(5):1110-24
pubmed: 21115039
Am J Psychiatry. 2008 Aug;165(8):1015-23
pubmed: 18381902
Nat Rev Neurosci. 2010 Apr;11(4):264-74
pubmed: 20216547
Front Psychiatry. 2012 May 08;3:42
pubmed: 22586412
Schizophr Bull. 2019 Jun 18;45(4):892-901
pubmed: 30169884